Four patients with severe muscle cramps were reported. In two of them the electrical signs of neuromyotonia were demonstrated. All the patients had undergone gastrectomy and all were immoderate consumers of alcohol. The neuromuscular disorder was reversible in all the patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

neuromyotonia alcoholic
4
patients
4
alcoholic patients
4
patients gastrectomy
4
gastrectomy patients
4
patients severe
4
severe muscle
4
muscle cramps
4
cramps reported
4
reported electrical
4

Similar Publications

The twin epidemics of obesity and type 2 diabetes continue to increase worldwide, so does the associated chronic liver disease, nonalcoholic fatty liver disease (NAFLD). Although NAFLD has been thought of as a benign liver disease, current evidence suggests that it is a complex liver disease that, for approximately 20% of patients, can progress to fibrosis, cirrhosis, hepatocellular carcinoma, liver transplant, and death. It is important to note that, given NAFLD's association with metabolic syndrome, the number one cause of death among those with NAFLD is related to cardiovascular diseases.

View Article and Find Full Text PDF

Nonalcoholic Fatty Liver Disease.

Endocrinol Metab Clin North Am

March 2023

Emory University School of Medicine, 775 Johnson Ferry Rad. NE, Atlanta, GA 30342, USA; Atlanta, GA, USA. Electronic address:

Management of nonalcoholic fatty liver disease (NAFLD) is crucial for type 2 diabetes (T2D) remission because they are linked through the common pathophysiology of insulin resistance and lipotoxicity. One in three patients with T2D has nonalcoholic steatohepatitis leading to fibrosis, cirrhosis, and hepatocellular carcinoma. Noninvasive testing with imaging and/or serum biomarkers can assess the risk for advanced liver disease.

View Article and Find Full Text PDF

A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis.

Aliment Pharmacol Ther

February 2023

Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA.

Background: Patients with nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D) or other components of metabolic syndrome are at high risk for disease progression. We proposed an algorithm to identify high-risk NAFLD patients in clinical practice using noninvasive tests (NITs).

Methods: Evidence about risk stratification of NAFLD using validated NITs was reviewed by a panel of NASH Experts.

View Article and Find Full Text PDF

Four patients with severe muscle cramps were reported. In two of them the electrical signs of neuromyotonia were demonstrated. All the patients had undergone gastrectomy and all were immoderate consumers of alcohol.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!